When we outsource animal experiments, we ensure that the outsourcing cont...
At Fujiyama Plant, employees periodically clean the area surrou...
Information Disclosure IR Activities ESG Activities
Compliance Promotion System To strengthen our compliance system, we ha...
Growth Strategy and Talent Strategy Towards Achievement of Corporate Phi...
To address natural environmental issues, including climate change, we ...
Concept of Health Management Efforts made to promote employees’ health...
Environmental Costs (Including Depreciation Costs) (Thousands o...
Our Approach to Human Rights In all its business activities in and out...
We set targets for sustainability, including environmental and occupation...
For more than 300 years since our foundation, we have walked han...
Basic Policy for Human Rights Human Rights Due Diligence Access to...
Ensuring Quality and Safety Initiatives for Proper Use of Pharmaceuti...
Scope 1+2 GHG emissions Reduction Roadmap ReducePromotion of e...
We have organized a nature positive sub-committee consisting of waste man...
We have adopted an organizational framework with Audit & Supervisor...
Analysis and Evaluation of Risks and Opportunities related to Climate Ch...
We donate toothbrushes/toothpastes produced by our sub...
As social structures evolve due to factors such as technological innovati...
ONO Pharmaceutical’s Compliance System Initiatives to Strengthen Comp...
The total volume of our industrial waste in FY2025 was 479.8 tons, a 338....
We strive to secure a market-competitive level of compensation, taking in...